MX367093B - Vacuna semi-viva del virus sincitial respiratorio. - Google Patents
Vacuna semi-viva del virus sincitial respiratorio.Info
- Publication number
- MX367093B MX367093B MX2015016882A MX2015016882A MX367093B MX 367093 B MX367093 B MX 367093B MX 2015016882 A MX2015016882 A MX 2015016882A MX 2015016882 A MX2015016882 A MX 2015016882A MX 367093 B MX367093 B MX 367093B
- Authority
- MX
- Mexico
- Prior art keywords
- semi
- respiratory syncytial
- syncytial virus
- rsv
- virus vaccine
- Prior art date
Links
- 241000725643 Respiratory syncytial virus Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000711408 Murine respirovirus Species 0.000 abstract 4
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 abstract 2
- 230000002950 deficient Effects 0.000 abstract 2
- 230000010076 replication Effects 0.000 abstract 2
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18834—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18841—Use of virus, viral particle or viral elements as a vector
- C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18861—Methods of inactivation or attenuation
- C12N2760/18862—Methods of inactivation or attenuation by genetic engineering
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13002973 | 2013-06-10 | ||
| PCT/EP2014/001575 WO2014198407A1 (en) | 2013-06-10 | 2014-06-10 | Semi-live respiratory syncytial virus vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015016882A MX2015016882A (es) | 2016-10-03 |
| MX367093B true MX367093B (es) | 2019-08-05 |
Family
ID=48578771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015016882A MX367093B (es) | 2013-06-10 | 2014-06-10 | Vacuna semi-viva del virus sincitial respiratorio. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160120974A1 (enExample) |
| EP (1) | EP3008190A1 (enExample) |
| JP (1) | JP2016521566A (enExample) |
| KR (1) | KR20160025553A (enExample) |
| CN (1) | CN105378090B (enExample) |
| AU (1) | AU2014280545A1 (enExample) |
| BR (1) | BR112015030697A2 (enExample) |
| CA (1) | CA2914821A1 (enExample) |
| EA (1) | EA201592298A1 (enExample) |
| HK (1) | HK1223644A1 (enExample) |
| MX (1) | MX367093B (enExample) |
| WO (1) | WO2014198407A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016144675A1 (en) * | 2015-03-06 | 2016-09-15 | Medimmune, Llc | Vaccine dose and use thereof |
| EP3309251A4 (en) * | 2015-06-12 | 2019-03-13 | Mie University | HUMAN PARAIN FLUENZA TYPE 2 VIRUS VIRUS VECTOR AND VACCINE |
| CN106362144B (zh) * | 2016-10-31 | 2021-02-09 | 武汉三利生物技术有限公司 | 呼吸道合胞病毒疫苗 |
| KR20220164642A (ko) | 2021-06-05 | 2022-12-13 | 이민욱 | 즉석 라면 조리기 |
| CA3257090A1 (en) * | 2022-05-25 | 2023-11-30 | Max Planck Gesellschaft | REDUCED VECTOR ANTIGENICITY VACCINE |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005006388A1 (de) * | 2005-02-11 | 2006-08-24 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Replikationsdefiziente RNA-Viren als Impfstoffe |
| KR20080016955A (ko) * | 2005-06-14 | 2008-02-22 | 디나벡크 가부시키가이샤 | 항체의 제작방법 |
-
2014
- 2014-06-10 US US14/896,866 patent/US20160120974A1/en not_active Abandoned
- 2014-06-10 EA EA201592298A patent/EA201592298A1/ru unknown
- 2014-06-10 MX MX2015016882A patent/MX367093B/es active IP Right Grant
- 2014-06-10 KR KR1020167000452A patent/KR20160025553A/ko not_active Ceased
- 2014-06-10 EP EP14729863.2A patent/EP3008190A1/en not_active Withdrawn
- 2014-06-10 BR BR112015030697A patent/BR112015030697A2/pt not_active IP Right Cessation
- 2014-06-10 HK HK16111701.9A patent/HK1223644A1/zh unknown
- 2014-06-10 WO PCT/EP2014/001575 patent/WO2014198407A1/en not_active Ceased
- 2014-06-10 JP JP2016518867A patent/JP2016521566A/ja active Pending
- 2014-06-10 CN CN201480039677.4A patent/CN105378090B/zh not_active Expired - Fee Related
- 2014-06-10 AU AU2014280545A patent/AU2014280545A1/en not_active Abandoned
- 2014-06-10 CA CA2914821A patent/CA2914821A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016521566A (ja) | 2016-07-25 |
| EA201592298A1 (ru) | 2016-06-30 |
| WO2014198407A1 (en) | 2014-12-18 |
| CA2914821A1 (en) | 2014-12-18 |
| EP3008190A1 (en) | 2016-04-20 |
| BR112015030697A2 (pt) | 2017-08-22 |
| US20160120974A1 (en) | 2016-05-05 |
| CN105378090B (zh) | 2020-07-10 |
| HK1223644A1 (zh) | 2017-08-04 |
| CN105378090A (zh) | 2016-03-02 |
| AU2014280545A1 (en) | 2015-12-24 |
| MX2015016882A (es) | 2016-10-03 |
| KR20160025553A (ko) | 2016-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500856A1 (en) | Respiratory syncytial virus vaccine | |
| EP4349404A3 (en) | Respiratory virus vaccines | |
| MX2022001105A (es) | Anticuerpos anti tigit. | |
| NZ630649A (en) | Vaccine against rsv | |
| EP3693046C0 (en) | PATIENT INTERFACE SYSTEM FOR THE TREATMENT OF RESPIRATORY DISORDERS | |
| CL2015003655A1 (es) | Polipéptidos f de prefusión del virus sincicial respiratorio (rsv) solubles y estabilizados | |
| PH12016502220A1 (en) | Means and methods for treating cmv | |
| HK1243714A1 (zh) | 制备取代的核苷类似物的方法 | |
| PH12016502555A1 (en) | Methods of preparing substituted nucleotide analogs | |
| EP4591936A3 (en) | Treatment of respiratory diseases | |
| MX2015015188A (es) | Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab. | |
| EP3183241A4 (en) | Catalyst and process for producing 2,5-furandicarboxylic acid from hydromethylfurfural in water | |
| MD20150109A2 (ro) | Construcţii proteice mitocondriale şi utilizările acestora | |
| IL254242A0 (en) | Dual signaling fusion proteins and methods of using them to treat diseases | |
| MX2015016882A (es) | Vacuna semi-viva del virus respiratorio sincitial. | |
| SI3400225T1 (sl) | Pentanojske kisline substituirane s pirolo-(2-3,b)pirimidin-piridini za zdravljenje okužb z virusom gripe | |
| MX367094B (es) | Vacuna semi-viva del virus sincitial respiratorio. | |
| PH12017501872A1 (en) | Methods of treating diseases | |
| MX2015012300A (es) | Procedimiento para la preparacion de 4-amino-1-(1s,4r,5s)-2-fluoro -4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirimidin-2-on a. | |
| AU2015901032A0 (en) | Treatment of respiratory diseases | |
| MA39900A (fr) | Vaccins à base d'acide nucléique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |